Loading...
Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy
One arising challenge in the treatment of breast cancer is development of therapeutic resistance to trastuzumab, an antibody targeting the human epidermal growth factor receptor-2 (HER2) which is frequently amplified in breast cancers. In this study, we provide evidence that elevated level of the re...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3859619/ https://ncbi.nlm.nih.gov/pubmed/20028874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-09-1845 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|